• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPP2R2A作为前列腺癌易感基因的评估:一项全面的种系和体细胞研究。

Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study.

作者信息

Cheng Yu, Liu Wennuan, Kim Seong-Tae, Sun Jishan, Lu Lingyi, Sun Jielin, Zheng Siqun Lilly, Isaacs William B, Xu Jianfeng

机构信息

Center for Cancer Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

出版信息

Cancer Genet. 2011 Jul;204(7):375-81. doi: 10.1016/j.cancergen.2011.05.002.

DOI:10.1016/j.cancergen.2011.05.002
PMID:21872824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3722858/
Abstract

PPP2R2A, mapped to 8p21.2, codes for the α isoform of the regulatory B55 subfamily of protein phosphatase 2 (PP2A). PP2A is one of the four major serine/threonine phosphatases and is implicated in the negative control of cell growth and division. Because of its known functions and location within a chromosomal region where evidence for linkage and somatic loss of heterozygosity was found, we hypothesized that either somatic copy number changes or germline sequence variants in PPP2R2A may increase prostate cancer (PCa) risk. We examined PPP2R2A deletion status in 141 PCa samples using Affymetrix SNP arrays. It was found that PPP2R2A was commonly (67.1%) deleted in tumor samples, including a homozygous deletion in three tumors (2.1%). We performed a mutation screen for PPP2R2A in 96 probands of hereditary prostate cancer families. No high risk mutations were identified. In addition, we re-analyzed 10 SNPs of PPP2R2A in sporadic PCa cases and controls. No significant differences in the allele and genotype frequencies were observed among either PCa cases and controls or PCa aggressive and non-aggressive cases. Taken together, these results suggest that a somatic deletion rather than germline sequence variants of PPP2R2A may play a more important role in PCa susceptibility.

摘要

PPP2R2A基因定位于8p21.2,编码蛋白磷酸酶2(PP2A)调节性B55亚家族的α异构体。PP2A是四种主要的丝氨酸/苏氨酸磷酸酶之一,参与细胞生长和分裂的负调控。鉴于其已知功能以及位于发现连锁和杂合性体细胞缺失证据的染色体区域内,我们推测PPP2R2A的体细胞拷贝数变化或种系序列变异可能会增加前列腺癌(PCa)风险。我们使用Affymetrix SNP阵列检测了141例PCa样本中PPP2R2A的缺失状态。结果发现,PPP2R2A在肿瘤样本中普遍缺失(67.1%),其中三例肿瘤(2.1%)存在纯合缺失。我们对96个遗传性前列腺癌家族的先证者进行了PPP2R2A的突变筛查。未发现高风险突变。此外,我们重新分析了散发性PCa病例和对照中PPP2R2A的10个单核苷酸多态性。在PCa病例与对照之间或PCa侵袭性与非侵袭性病例之间,等位基因和基因型频率均未观察到显著差异。综上所述,这些结果表明,PPP2R2A的体细胞缺失而非种系序列变异可能在PCa易感性中起更重要的作用。

相似文献

1
Evaluation of PPP2R2A as a prostate cancer susceptibility gene: a comprehensive germline and somatic study.PPP2R2A作为前列腺癌易感基因的评估:一项全面的种系和体细胞研究。
Cancer Genet. 2011 Jul;204(7):375-81. doi: 10.1016/j.cancergen.2011.05.002.
2
Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility.PTEN 种系序列变异在遗传性和非遗传性前列腺癌易感性中没有重要作用。
J Hum Genet. 2011 Jul;56(7):496-502. doi: 10.1038/jhg.2011.48. Epub 2011 Jun 2.
3
Germline ATBF1 mutations and prostate cancer risk.种系ATBF1突变与前列腺癌风险
Prostate. 2006 Jul 1;66(10):1082-5. doi: 10.1002/pros.20430.
4
Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.英国年轻发病前列腺癌病例中的胚系 DNA 修复基因突变:更广泛的遗传面板证据。
Eur Urol. 2019 Sep;76(3):329-337. doi: 10.1016/j.eururo.2019.01.050. Epub 2019 Feb 15.
5
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.纯合缺失和复发性扩增涉及前列腺癌相关新基因。
Neoplasia. 2008 Aug;10(8):897-907. doi: 10.1593/neo.08428.
6
Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.HPC2/ELAC2基因的Ser217Leu多态性与日本男性前列腺癌风险相关。
Int J Cancer. 2003 Nov 1;107(2):224-8. doi: 10.1002/ijc.11347.
7
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.HPC2/ELAC2在家族性或散发性前列腺癌患者中的连锁与关联评估。
Am J Hum Genet. 2001 Apr;68(4):901-11. doi: 10.1086/319513. Epub 2001 Mar 14.
8
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.NKX3.1的种系突变与遗传性前列腺癌共分离,并改变同源结构域的结构和功能。
Cancer Res. 2006 Jan 1;66(1):69-77. doi: 10.1158/0008-5472.CAN-05-1550.
9
Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.评估DLC1作为前列腺癌易感基因:突变筛查与关联研究。
Mutat Res. 2003 Jul 25;528(1-2):45-53. doi: 10.1016/s0027-5107(03)00081-2.
10
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.来自高危法裔加拿大乳腺癌/卵巢癌家族的乳腺癌病例中ATR序列变异的突变分析与特征描述
BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230.

引用本文的文献

1
The balance between B55α and Greatwall expression levels predicts sensitivity to Greatwall inhibition in cancer cells.B55α与Greatwall表达水平之间的平衡预示着癌细胞对Greatwall抑制的敏感性。
Nat Commun. 2025 Aug 27;16(1):8016. doi: 10.1038/s41467-025-62943-z.
2
Characterization of RNF144B and PPP2R2A identified by a novel approach using TCGA data in ovarian cancer.通过使用TCGA数据的新方法鉴定出的RNF144B和PPP2R2A在卵巢癌中的特征分析。
Sci Rep. 2025 Feb 13;15(1):5414. doi: 10.1038/s41598-024-76801-3.
3
Low expression promotes sensitivity to CHK1 inhibition in high-grade serous ovarian cancer.

本文引用的文献

1
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.卵巢透明细胞癌中染色质重塑基因 ARID1A 的频繁突变。
Science. 2010 Oct 8;330(6001):228-31. doi: 10.1126/science.1196333. Epub 2010 Sep 8.
2
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
3
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.microRNA-31 通过抑制特定的肿瘤抑制因子在小鼠和人肺癌细胞中发挥致癌 microRNA 的作用。
低表达促进高级别浆液性卵巢癌对CHK1抑制的敏感性。
Theranostics. 2024 Nov 4;14(19):7450-7469. doi: 10.7150/thno.96879. eCollection 2024.
4
PP2A B55α inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer.PP2A B55α 通过调节非小细胞肺癌中 Slug 的表达抑制上皮-间充质转化。
Cancer Lett. 2024 Aug 28;598:217110. doi: 10.1016/j.canlet.2024.217110. Epub 2024 Jul 8.
5
Molecular Role of Protein Phosphatases in Alzheimer's and Other Neurodegenerative Diseases.蛋白磷酸酶在阿尔茨海默病及其他神经退行性疾病中的分子作用
Biomedicines. 2024 May 15;12(5):1097. doi: 10.3390/biomedicines12051097.
6
Altering phosphorylation in cancer through PP2A modifiers.通过PP2A修饰剂改变癌症中的磷酸化作用。
Cancer Cell Int. 2024 Jan 6;24(1):11. doi: 10.1186/s12935-023-03193-1.
7
VPA mediates bidirectional regulation of cell cycle progression through the PPP2R2A-Chk1 signaling axis in response to HU.VPA 通过 PPP2R2A-Chk1 信号轴介导细胞周期进程的双向调节,以响应 HU。
Cell Death Dis. 2023 Feb 13;14(2):114. doi: 10.1038/s41419-023-05649-8.
8
PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers.PP2A 甲基转移酶 PME-1 抑制失巢凋亡,与 PTEN 缺陷型前列腺癌的治疗复发相关。
Mol Oncol. 2023 Jun;17(6):1007-1023. doi: 10.1002/1878-0261.13353. Epub 2023 Apr 18.
9
Pleiotropy of PP2A Phosphatases in Cancer with a Focus on Glioblastoma Wildtype.PP2A磷酸酶在癌症中的多效性,重点关注胶质母细胞瘤野生型。
Cancers (Basel). 2022 Oct 25;14(21):5227. doi: 10.3390/cancers14215227.
10
Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese.PP2A亚基基因的遗传变异增加中国人患原发性肝癌的风险。
Pharmgenomics Pers Med. 2021 Dec 1;14:1565-1574. doi: 10.2147/PGPM.S335555. eCollection 2021.
J Clin Invest. 2010 Apr;120(4):1298-309. doi: 10.1172/JCI39566. Epub 2010 Mar 8.
4
Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer.纯合缺失和复发性扩增涉及前列腺癌相关新基因。
Neoplasia. 2008 Aug;10(8):897-907. doi: 10.1593/neo.08428.
5
Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.通过将蛋白磷酸酶2A全酶的B55α调节亚基靶向Akt来调节Akt的苏氨酸-308磷酸化、细胞增殖和存活。
J Biol Chem. 2008 Jan 25;283(4):1882-92. doi: 10.1074/jbc.M709585200. Epub 2007 Nov 27.
6
Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.8号染色体长臂24区两个不连锁基因座与欧裔美国人前列腺癌风险之间的关联。
J Natl Cancer Inst. 2007 Oct 17;99(20):1525-33. doi: 10.1093/jnci/djm169. Epub 2007 Oct 9.
7
A new multipoint method for genome-wide association studies by imputation of genotypes.一种通过基因型插补进行全基因组关联研究的新的多点方法。
Nat Genet. 2007 Jul;39(7):906-13. doi: 10.1038/ng2088. Epub 2007 Jun 17.
8
Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p.前列腺癌的体细胞缺失分析与前列腺癌家族的种系连锁分析相结合,揭示了位于8p的两个前列腺癌基因的小的共有区域。
Cancer Res. 2007 May 1;67(9):4098-103. doi: 10.1158/0008-5472.CAN-06-4570.
9
Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma.儿童畸胎瘤中肿瘤抑制基因CHEK2与蛋白磷酸酶2(PPP2R2A)调节亚基B基因的融合。
Neoplasia. 2006 May;8(5):413-8. doi: 10.1593/neo.06139.
10
Involvement of PP2A in viral and cellular transformation.蛋白磷酸酶2A在病毒及细胞转化中的作用。
Oncogene. 2005 Nov 21;24(52):7746-55. doi: 10.1038/sj.onc.1209038.